ACACA
Basic information
Region (hg38): 17:37084992-37406836
Previous symbols: [ "ACAC", "ACC" ]
Links
Phenotypes
GenCC
Source:
- acetyl-coa carboxylase deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Acetyl-CoA carboxylase deficiency | AR | Biochemical | The conditon can manifest with early-onset neurological sequelae, and medical and dietary management (eg, with vitamin B2, carnitine, and medium chain triglycerides) has been reported as potentially beneficial | Biochemical; Neurologic | 34552920; 36709796 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACACA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 59 | 70 | ||||
missense | 108 | 113 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 9 | 17 | 5 | 31 | ||
non coding | 41 | 21 | 65 | |||
Total | 0 | 0 | 118 | 103 | 32 |
Variants in ACACA
This is a list of pathogenic ClinVar variants found in the ACACA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-37087350-C-T | Uncertain significance (Dec 18, 2022) | |||
17-37087388-C-G | Likely benign (Dec 02, 2022) | |||
17-37087425-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
17-37088918-G-A | Benign (Jun 16, 2024) | |||
17-37088926-C-T | Likely benign (Dec 28, 2021) | |||
17-37088927-G-A | Likely benign (Aug 14, 2023) | |||
17-37088952-G-A | ACACA-related disorder | Benign (Dec 10, 2023) | ||
17-37088958-G-A | Likely benign (Dec 09, 2023) | |||
17-37088997-C-T | Likely benign (Nov 27, 2023) | |||
17-37089042-C-T | ACACA-related disorder | Benign (Nov 05, 2024) | ||
17-37089043-G-A | Acetyl-CoA: carboxylase deficiency | Uncertain significance (Jun 10, 2023) | ||
17-37089058-T-C | not specified | Uncertain significance (Jun 02, 2024) | ||
17-37097008-T-C | Likely benign (Jun 27, 2022) | |||
17-37097011-C-T | Likely benign (Nov 21, 2023) | |||
17-37097064-C-G | not specified | Uncertain significance (Aug 28, 2024) | ||
17-37097075-T-C | not specified | Uncertain significance (Apr 28, 2022) | ||
17-37097148-T-A | Uncertain significance (Jun 05, 2022) | |||
17-37097816-A-C | Likely benign (Jun 15, 2024) | |||
17-37097827-T-TA | Uncertain significance (Apr 14, 2023) | |||
17-37097856-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
17-37097868-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
17-37097909-G-T | Acetyl-CoA: carboxylase deficiency | Pathogenic/Likely pathogenic (Jan 31, 2024) | ||
17-37097916-G-A | ACACA-related disorder | Benign (Jan 13, 2025) | ||
17-37097957-C-T | Uncertain significance (Jan 29, 2024) | |||
17-37097958-G-A | Acetyl-CoA: carboxylase deficiency | Uncertain significance (Oct 29, 2024) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the rate-limiting reaction in the biogenesis of long-chain fatty acids. Carries out three functions: biotin carboxyl carrier protein, biotin carboxylase and carboxyltransferase. {ECO:0000269|PubMed:20952656}.;
- Disease
- DISEASE: Acetyl-CoA carboxylase 1 deficiency (ACACAD) [MIM:613933]: An inborn error of de novo fatty acid synthesis associated with severe brain damage, persistent myopathy and poor growth. {ECO:0000269|PubMed:6114432}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pyruvate metabolism - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;Pyruvate Dehydrogenase Complex Deficiency;Malonyl-coa decarboxylase deficiency;Primary hyperoxaluria II, PH2;Pyruvate kinase deficiency;Malonic Aciduria;Leigh Syndrome;Propanoate Metabolism;Pyruvate Metabolism;Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency);Methylmalonic Aciduria Due to Cobalamin-Related Disorders;Fatty Acid Biosynthesis;AMP-activated Protein Kinase (AMPK) Signaling;Sterol Regulatory Element-Binding Proteins (SREBP) signalling;Leptin signaling pathway;Corticotropin-releasing hormone signaling pathway;JAK-STAT;Mesodermal Commitment Pathway;Fatty Acid Biosynthesis;VEGFA-VEGFR2 Signaling Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Leptin and adiponectin;Lipid Metabolism Pathway;Liver steatosis AOP;Pathways in clear cell renal cell carcinoma;Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway;Biotin transport and metabolism;reversal of insulin resistance by leptin;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Ghrelin;Fatty acid metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;fatty acid biosynthesis initiation;biotin-carboxyl carrier protein assembly;Pyruvate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.732
Intolerance Scores
- loftool
- 0.0461
- rvis_EVS
- -1.61
- rvis_percentile_EVS
- 2.96
Haploinsufficiency Scores
- pHI
- 0.468
- hipred
- Y
- hipred_score
- 0.639
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.983
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acaca
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- tissue homeostasis;acetyl-CoA metabolic process;fatty acid biosynthetic process;carnitine shuttle;protein metabolic process;positive regulation of cellular metabolic process;regulation of cholesterol biosynthetic process;fatty-acyl-CoA biosynthetic process;protein homotetramerization;lipid homeostasis;cellular response to prostaglandin E stimulus;malonyl-CoA biosynthetic process
- Cellular component
- fibrillar center;cytosol;actin cytoskeleton
- Molecular function
- acetyl-CoA carboxylase activity;biotin carboxylase activity;protein binding;ATP binding;identical protein binding;metal ion binding